The effects of the preferential dopamine D3 receptor antagonist S33138 on ethanol binge drinking in C57BL/6J mice

Synapse

Volumn 66, Issue 11, 2012, Pages 975-978

  Rice, Onarae V ^a   Patrick, Jay ^a   Schonhar, Charles D ^a   Ning, Haoran ^a   Ashby, Charles R ^b  

^a FURMAN UNIVERSITY   (United States)

^b ST JOHN'S UNIVERSITY   (United States)

Author keywords

Binge drinking; D3 receptor; Dopamine; Ethanol

Indexed keywords

ALCOHOL; N [4 [2 (8 CYANO 1,3A,4,9B TETRAHYDRO 1 BENZOPYRANO[3,4 C]PYRROL 2(3H) YL)ETHYL]PHENYL]ACETAMIDE;

ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINGE EATING DISORDER; CONTROLLED STUDY; DOSE RESPONSE; FLUID INTAKE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THERAPY EFFECT;

ACETANILIDES; ANIMALS; BENZOPYRANS; BINGE DRINKING; DRINKING; ETHANOL; MALE; MICE; MICE, INBRED C57BL; RECEPTORS, DOPAMINE D3;

EID: 84866161875     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.21575     Document Type: Article

References (13)

1. Gardner EL. 2011. Addiction and brain reward and antireward pathways. Adv Psychosom Med. 30: 22-60.
2. 3 receptors in oral operant alcohol self-administration and reinstatement of alcohol-seeking behavior in mice. Addict Biol 12: 35-50
3. Heidbreder CA, Newman AH. 2010. Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders. Ann NY Acad Sci 1187: 4-34.
4. 2 receptor antagonist and potential antipsychotic agent: I. Receptor-binding profile and functional actions at G-protein-coupled receptors. J Pharmacol Exp Therap 324: 587-599.
5. Millan MJ, Svenningsson P, Ashby CRJr, Hill M, Egeland M, Dekeyne A, Brocco M, Di Cara B, Lejeune F, Thomasson N, Munoz C, Mocaër E, Crossman A, Cistarelli L, Girardon S, Iob L, Veiga S, Gobert A. 2008b. S33138 [N-[4-[2-[(3aS, 9bR)-8-cyano-1, 3a, 4, 9b-tetrahydro[1]-benzopyrano[3, 4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent. II. A neurochemical, electrophysiological and behavioral characterization in vivo. J Pharmacol Exp Ther 324: 600-611.
6. 3 receptor antagonist S33138 inhibits cocaine reward and cocaine-triggered relapse to drug-seeking behavior in rats. Neuropharmacology 56: 752-760.
7. Song R, Yang RF, Wu N, Su RB, Li J, Peng XQ, Li X, Gaál J, Xi ZX, Gardner EL. 2012. YQA14: A novel dopamine D(3) receptor antagonist that inhibits cocaine self-administration in rats and mice, but not in D(3) receptor-knockout mice. Addict Biol 17: 259-273.
8. 3 receptor agonist BP-897 attenuate methamphetamine-enhanced brain stimulation reward in rats. Psychopharmacology 196: 533-542.
9. Substance Abuse and Mental Health Services Administration. 2010. Results from the 2009 National Survey on Drug Use and Health: Volume 1. Summary of National Findings (Office of Applied Studies, NSDUH Series H-38A, HHS Publication No. SMA 10-4586 Findings). Rockville, MD.
10. 3 receptor antagonist SB-277011-A attenuates ethanol consumption in ethanol preferring (P) and non-preferring (NP) rats. Pharmacol Biochem Behav 81: 190-197.
11. 3 receptor plays an essential role in alcohol-seeking and relapse. FASEB J 20: 2223-2233.
12. WHO. 2009. Management of substance abuse: Alcohol [cited 2009 June 1].
13. Wise RA. 2008. Dopamine and reward: The anhedonia hypothesis 30 years on. Neurotox Res 14; 169-183.